How to appeal a Humana endocrine (non-diabetes) denial

The framework that applies to your appeal

Medicare Advantage plans follow a separate appeal track from commercial plans. Reconsideration must be requested within 60 days; if the plan misses its deadline, the case auto-forwards to the IRE (Maximus).

Humana-specific note: Heavily Medicare Advantage focused. MA-specific appeal track (42 CFR Part 422 Subpart M) applies — 60 days to request reconsideration, NOT the 180 days for commercial plans. Auto-forward to IRE (Maximus) if Humana misses deadline.

What Humana's policy requires for endocrine (non-diabetes)

Cited policy: Humana Pharmacy Coverage Policy — Palopegteriparatide (Yorvipath)

Chronic hypoparathyroidism with low Ca + inappropriately low/normal PTH. Hypercalciuria or other adverse effects of conventional therapy.

How Humana denies endocrine (non-diabetes) — and how to counter it

Where Humana pushes back: 1) Calcium + calcitriol 'sufficient'; 2) 'Natpara recalled — class unproven'; 3) Cost-prohibitive.

Counter-arguments that hold up: Document hypercalciuria, nephrocalcinosis, renal function decline, ER visits for hypocalcemia, QoL impact (PaTHway endpoints). Yorvipath has independent FDA approval Aug 2024 + PaTHway data — distinct from Natpara. PTH(1-34) prodrug mechanism.

What Humana typically denies for endocrine (non-diabetes)

Across Humana's commercial and Medicare books, denials cluster around a small number of patterns. For endocrine (non-diabetes), expect:

• MA plan step therapy on Part B drugs
• Skilled nursing facility days
• Prior auth on specialty drugs
• OON emergency reduction

Treatments most often denied in this category

These are the endocrine (non-diabetes) treatments most often flagged for prior auth, step therapy, or medical necessity review:

• TRT
• Tepezza (TED)
• Crenessity (CAH)
• Isturisa (Cushing's)
• Recorlev
• Mycapssa

How to submit the appeal to Humana

1. Read the denial letter — note the exact denial reason code and the appeal deadline (60 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Humana cited in the denial.
3. File the appeal through Humana's portal (members: https://www.humana.com ; providers: https://www.humana.com/provider). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In KY, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See Humana's prior-authorization criteria by drug: Humana PA criteria on ApprovalHelp.